Yanliang Bai
#7 Weiwu Road
Zhengzhou, 450003, China
Zhengzhou, 450003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study.
Journal: Drug design, development and therapy
Published: March 07, 2026
Seven-day Venetoclax Combined With Dose-adjusted Intensive Chemotherapy as Induction Treatment in Newly Diagnosed Acute Myeloid Leukemia.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 06, 2026
Prognostic Significance of Systemic Immune-Inflammation Index in Patients with de Novo non‑M3 Acute Myeloid Leukemia.
Journal: Journal of inflammation research
Published: July 10, 2025
Long-term follow-up of patients with relapsed/refractory multiple myeloma after BCMA CAR-T-cell therapy.
Journal: Frontiers in immunology
Published: June 20, 2025
Identification of a m6A-immune-related risk model for predicting prognosis, immune microenvironment, and drug responses in acute myeloid leukemia.
Journal: Scientific reports
Published: May 27, 2025
Association of product of platelet and neutrophil count with monoclonal gammopathy of undetermined significance: a cross-sectional analysis of the NHANES.
Journal: Blood research
Published: April 12, 2025
Role of the bone marrow microenvironment in multiple myeloma: Impact of niches on drug resistance mechanisms.
Journal: Seminars in diagnostic pathology
Published: November 08, 2024
Multi-omics analysis reveals a feedback loop amplifying immune responses in acute graft-versus-host disease due to imbalanced gut microbiota and bile acid metabolism.
Journal: Journal of translational medicine
Published: April 30, 2024
Screening of a Prognostic Gene Signature for Relapsed/Refractory Acute Myeloid Leukemia Based on Altered Circulating CircRNA Profiles.
Journal: International journal of general medicine
Published: February 28, 2024
Last Updated: 09/26/2026